Avania Acquires Hull Associates LLC and Ironstone Product Development (IPD)
October 17, 2023
Avania, a global MedTech contract research organization based in the Netherlands, has acquired HULL ASSOCIATES LLC (Boston) and Ironstone Product Development (IPD) (Toronto) to strengthen its engineering design, product development, regulatory, and market access capabilities across medical devices, diagnostics and related product categories. The acquisitions expand Avania's strategic expertise in market access/reimbursement, health economics, early product development, and regulatory strategy to better support MedTech innovators from development through commercialization.
- Buyers
- Avania
- Targets
- HULL ASSOCIATES LLC, Ironstone Product Development (IPD)
- Industry
- Healthcare Services
- Location
- United States; Canada
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Astorg Acquires Majority Stake in Avania
June 20, 2022
Healthcare Services
Astorg has acquired a majority stake in Avania from Kester Capital, with Kester expected to retain a minority position and management also reinvesting. Avania, a Bilthoven-headquartered MedTech-focused clinical CRO, will use Astorg's capital and network to accelerate organic growth and pursue M&A to build a scaled, global MedTech CRO platform.
-
Avania Acquires IMARC
June 22, 2021
Healthcare Services
Avania, a global medical-technology contract research organization (CRO) based in Bilthoven, Netherlands, has acquired IMARC, a Strongsville, Ohio–based medical device CRO. The acquisition expands Avania's U.S. footprint and capabilities in device clinical research (monitoring, auditing, safety, data management and training) while providing IMARC clients access to Avania's international network and enhanced services.
-
Avania Acquires MAXIS
February 7, 2023
Medical Devices
Avania, the Bilthoven-based MedTech-focused contract research organization (CRO), has acquired MAXIS, a medical-technology development services provider with offices in San Jose, California and Frankfurt am Main, Germany. The deal expands Avania's pre-clinical engineering, design validation, regulatory affairs, and field clinical/trial management capabilities and extends its international footprint.
-
Avania Acquires Anagram
October 8, 2024
Healthcare Services
Avania, a global MedTech contract research organization (CRO), has acquired Anagram, a Barcelona-based MedTech CRO, to expand its CRO footprint into Spain and Southern Europe. The acquisition adds Anagram’s imaging core lab and therapeutic expertise in cardiology, neurology and oncology, strengthening Avania’s regional presence and clinical capabilities.
-
Platinum Equity Acquires Controlling Stake in Inventia Healthcare
August 29, 2024
Pharmaceuticals
Platinum Equity has acquired a controlling stake in Inventia Healthcare Limited's core Oral Solid Dosage (OSD) business from India Life Sciences Fund III (advised by InvAscent), NYLIM Jacob Ballas India Fund III and affiliates of the founding Shah family, with the Shah family retaining a minority stake. Headquartered in Mumbai, Inventia is a U.S. FDA- and MHRA-accredited contract manufacturer and developer of generic OSD products serving more than 100 customers across 40+ countries; Platinum plans to expand the business organically and via add-on acquisitions.
-
Stenson Tamaddon Acquires Huljev & Associates (R&D Tax Services)
February 9, 2023
Accounting & Tax
Stenson Tamaddon has acquired Ilija Huljev and Huljev & Associates to expand its research and development (R&D) tax credit capabilities. Ilija Huljev joins Stenson Tamaddon as managing director of R&D tax services to help scale the firm's R&D tax offering and increase awareness of credits for small businesses nationwide.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.